TWD 32.3
(1.1%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 231.91 Million TWD | -8.23% |
2022 | 252.72 Million TWD | 57.08% |
2021 | 160.88 Million TWD | 35.68% |
2020 | 118.57 Million TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2023 FY | 231.91 Million TWD | -8.23% |
2022 FY | 252.72 Million TWD | 57.08% |
2021 FY | 160.88 Million TWD | 35.68% |
2020 FY | 118.57 Million TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
BIONET Corp. | 1.12 Billion TWD | 79.427% |
DIVA Laboratories, Ltd. | 893.84 Million TWD | 74.054% |
Genetics Generation Advancement Corp. | 592.5 Million TWD | 60.858% |
Welgene Biotech Co.,Ltd. | 280.54 Million TWD | 17.334% |
Puriblood Medical Co., Ltd. | 125.26 Million TWD | -85.136% |